Tumor-produced versican V1 enhances hCAP18/LL-37 expression in macrophages through activation of TLR2 and vitamin D3 signaling to promote ovarian cancer progression in vitro.
Tumor-associated macrophages have been shown to promote tumor growth. They may have an obligatory function in angiogenesis, invasion, and metastasis through release of inflammatory mediators. Their presence in ovarian cancer has been correlated with poor prognosis in these patients. The human cation...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC3570526?pdf=render |
| _version_ | 1819231491311271936 |
|---|---|
| author | Dong Li Xuan Wang Jun-Lu Wu Wen-Qiang Quan Li Ma Fan Yang Kai-Yin Wu Hai-Ying Wan |
| author_facet | Dong Li Xuan Wang Jun-Lu Wu Wen-Qiang Quan Li Ma Fan Yang Kai-Yin Wu Hai-Ying Wan |
| author_sort | Dong Li |
| collection | DOAJ |
| description | Tumor-associated macrophages have been shown to promote tumor growth. They may have an obligatory function in angiogenesis, invasion, and metastasis through release of inflammatory mediators. Their presence in ovarian cancer has been correlated with poor prognosis in these patients. The human cationic antimicrobial protein-18 (hCAP18)/LL-37 was originally identified as an effector molecule of the innate immune system. It is released by innate immune cells, such as macrophages, to combat microorganisms. Previous studies have characterized the hCAP18/LL-37 as a growth factor that has been shown to promote ovarian tumor progression. However, the role hCAP18/LL-37 has in macrophage-promoted ovarian tumor development and how its expression is controlled in this context remains poorly understood. Here, we demonstrate in co-culture experiments of macrophages and ovarian cancer cells a significant increase in the in vitro proliferation and invasiveness of the tumor cells is observed. These enhanced growth and invasion properties correlated with hCAP18/LL-37 induction. HCAP18/LL-37 expression was diminished by addition of two neutralizing antibodies, TLR2 or TLR6, as well as Cyp27B1 or VDR inhibitors. Furthermore, either the TLR2 or TLR6 antibody reduced vitamin D3 signaling and tumor cell progression in vitro. Addition of Cyp27B1 or VDR inhibitors abrogated TLR2/6 activation-induced expression of hCAP18/LL-37 in macrophages. Knockdown of tumor-produced versican V1 by RNAi in these tumor cells led to a decreased induction of hCAP18/LL-37 in macrophages. Versican V1 knockdown also inhibited TLR2 and vitamin D3 signaling, as well as growth and invasiveness of these tumor cells in the in vitro co-culture. In summary, we have found that versican V1 enhances hCAP18/LL-37 expression in macrophages through activation of TLR2 and subsequent vitamin D-dependent mechanisms which promote ovarian tumor progression in vitro. |
| first_indexed | 2024-12-23T11:45:48Z |
| format | Article |
| id | doaj.art-14055b8353db43a5b26ee2e12668337f |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-23T11:45:48Z |
| publishDate | 2013-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-14055b8353db43a5b26ee2e12668337f2022-12-21T17:48:20ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0182e5661610.1371/journal.pone.0056616Tumor-produced versican V1 enhances hCAP18/LL-37 expression in macrophages through activation of TLR2 and vitamin D3 signaling to promote ovarian cancer progression in vitro.Dong LiXuan WangJun-Lu WuWen-Qiang QuanLi MaFan YangKai-Yin WuHai-Ying WanTumor-associated macrophages have been shown to promote tumor growth. They may have an obligatory function in angiogenesis, invasion, and metastasis through release of inflammatory mediators. Their presence in ovarian cancer has been correlated with poor prognosis in these patients. The human cationic antimicrobial protein-18 (hCAP18)/LL-37 was originally identified as an effector molecule of the innate immune system. It is released by innate immune cells, such as macrophages, to combat microorganisms. Previous studies have characterized the hCAP18/LL-37 as a growth factor that has been shown to promote ovarian tumor progression. However, the role hCAP18/LL-37 has in macrophage-promoted ovarian tumor development and how its expression is controlled in this context remains poorly understood. Here, we demonstrate in co-culture experiments of macrophages and ovarian cancer cells a significant increase in the in vitro proliferation and invasiveness of the tumor cells is observed. These enhanced growth and invasion properties correlated with hCAP18/LL-37 induction. HCAP18/LL-37 expression was diminished by addition of two neutralizing antibodies, TLR2 or TLR6, as well as Cyp27B1 or VDR inhibitors. Furthermore, either the TLR2 or TLR6 antibody reduced vitamin D3 signaling and tumor cell progression in vitro. Addition of Cyp27B1 or VDR inhibitors abrogated TLR2/6 activation-induced expression of hCAP18/LL-37 in macrophages. Knockdown of tumor-produced versican V1 by RNAi in these tumor cells led to a decreased induction of hCAP18/LL-37 in macrophages. Versican V1 knockdown also inhibited TLR2 and vitamin D3 signaling, as well as growth and invasiveness of these tumor cells in the in vitro co-culture. In summary, we have found that versican V1 enhances hCAP18/LL-37 expression in macrophages through activation of TLR2 and subsequent vitamin D-dependent mechanisms which promote ovarian tumor progression in vitro.http://europepmc.org/articles/PMC3570526?pdf=render |
| spellingShingle | Dong Li Xuan Wang Jun-Lu Wu Wen-Qiang Quan Li Ma Fan Yang Kai-Yin Wu Hai-Ying Wan Tumor-produced versican V1 enhances hCAP18/LL-37 expression in macrophages through activation of TLR2 and vitamin D3 signaling to promote ovarian cancer progression in vitro. PLoS ONE |
| title | Tumor-produced versican V1 enhances hCAP18/LL-37 expression in macrophages through activation of TLR2 and vitamin D3 signaling to promote ovarian cancer progression in vitro. |
| title_full | Tumor-produced versican V1 enhances hCAP18/LL-37 expression in macrophages through activation of TLR2 and vitamin D3 signaling to promote ovarian cancer progression in vitro. |
| title_fullStr | Tumor-produced versican V1 enhances hCAP18/LL-37 expression in macrophages through activation of TLR2 and vitamin D3 signaling to promote ovarian cancer progression in vitro. |
| title_full_unstemmed | Tumor-produced versican V1 enhances hCAP18/LL-37 expression in macrophages through activation of TLR2 and vitamin D3 signaling to promote ovarian cancer progression in vitro. |
| title_short | Tumor-produced versican V1 enhances hCAP18/LL-37 expression in macrophages through activation of TLR2 and vitamin D3 signaling to promote ovarian cancer progression in vitro. |
| title_sort | tumor produced versican v1 enhances hcap18 ll 37 expression in macrophages through activation of tlr2 and vitamin d3 signaling to promote ovarian cancer progression in vitro |
| url | http://europepmc.org/articles/PMC3570526?pdf=render |
| work_keys_str_mv | AT dongli tumorproducedversicanv1enhanceshcap18ll37expressioninmacrophagesthroughactivationoftlr2andvitamind3signalingtopromoteovariancancerprogressioninvitro AT xuanwang tumorproducedversicanv1enhanceshcap18ll37expressioninmacrophagesthroughactivationoftlr2andvitamind3signalingtopromoteovariancancerprogressioninvitro AT junluwu tumorproducedversicanv1enhanceshcap18ll37expressioninmacrophagesthroughactivationoftlr2andvitamind3signalingtopromoteovariancancerprogressioninvitro AT wenqiangquan tumorproducedversicanv1enhanceshcap18ll37expressioninmacrophagesthroughactivationoftlr2andvitamind3signalingtopromoteovariancancerprogressioninvitro AT lima tumorproducedversicanv1enhanceshcap18ll37expressioninmacrophagesthroughactivationoftlr2andvitamind3signalingtopromoteovariancancerprogressioninvitro AT fanyang tumorproducedversicanv1enhanceshcap18ll37expressioninmacrophagesthroughactivationoftlr2andvitamind3signalingtopromoteovariancancerprogressioninvitro AT kaiyinwu tumorproducedversicanv1enhanceshcap18ll37expressioninmacrophagesthroughactivationoftlr2andvitamind3signalingtopromoteovariancancerprogressioninvitro AT haiyingwan tumorproducedversicanv1enhanceshcap18ll37expressioninmacrophagesthroughactivationoftlr2andvitamind3signalingtopromoteovariancancerprogressioninvitro |